198 related articles for article (PubMed ID: 32514594)
1. Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.
Painvin B; Guillot P; Verdier MC; Gacouin A; Maamar A
Intensive Care Med; 2020 Sep; 46(9):1772-1773. PubMed ID: 32514594
[No Abstract] [Full Text] [Related]
2. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
3. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Martinez Navarro W; Ly L; Segal MS; Shukla AM
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
[No Abstract] [Full Text] [Related]
4. Very severe COVID-19 in the critically ill in Tunisia.
Saida IB; Ennouri E; Nachi R; Meddeb K; Mahmoud J; Thabet N; Jerbi S; Boussarsar M
Pan Afr Med J; 2020; 35(Suppl 2):136. PubMed ID: 33193951
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
6. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
7. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
8. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
[No Abstract] [Full Text] [Related]
9. Experience in the management of severe COVID-19 patients in an intensive care unit.
Sosa-García JO; Gutiérrez-Villaseñor AO; García-Briones A; Romero-González JP; Juárez-Hernández E; González-Chon O
Cir Cir; 2020; 88(5):569-575. PubMed ID: 33064694
[TBL] [Abstract][Full Text] [Related]
10. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Shah M; Sachdeva M; Dodiuk-Gad RP
Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
[No Abstract] [Full Text] [Related]
11. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
12. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
Harrigan JJ; Hubbard RA; Thomas S; Riello RJ; Bange E; Mamtani M; Mamtani R
J Gen Intern Med; 2020 Sep; 35(9):2826-2828. PubMed ID: 32542496
[No Abstract] [Full Text] [Related]
13. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
14. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
Shih RD; Johnson HM; Maki DG; Hennekens CH
Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
[No Abstract] [Full Text] [Related]
15. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
[TBL] [Abstract][Full Text] [Related]
16. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
17. How to manage rheumatic patients during the coronavirus pandemic.
Parisi S; Ditto MC; Finucci A; Fusaro E
Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
[No Abstract] [Full Text] [Related]
18. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
Kamp TJ; Hamdan MH; January CT
J Am Heart Assoc; 2020 Jun; 9(12):e016887. PubMed ID: 32463308
[No Abstract] [Full Text] [Related]
19. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
20. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
[Next] [New Search]